PTC Therapeutics Inc (PTCT) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.21x

PTC Therapeutics Inc (PTCT) has a Cash Flow Reinvestment Rate of 0.21x as of March 2025, reinvesting $186.89 Million (capex $2.53 Million plus investments $-184.36 Million) from operating cash flow of $870.10 Million. Explore PTC Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.21x
(Capex + Investments) / Operating CF

Total Reinvested

$186.89 Million
Capex + Investments

Operating Cash Flow

$870.10 Million
USD

Capital Expenditures

$2.53 Million
USD

PTC Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for PTC Therapeutics Inc across 1 annual periods. Also explore PTCT total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for PTC Therapeutics Inc (2025–2025)

Year-by-year capital reinvestment analysis for PTC Therapeutics Inc. For live market cap and broader valuation context, see market cap of PTC Therapeutics Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.80x $570.90 Million $711.20 Million $8.86 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow